Endovascular Management of Pelvic Congestion Syndrome

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age17-55
SponsorSohag University

About this trial

Pelvic congestion syndrome (PCS) is a common cause of chronic pelvic pain in women and is associated with pelvic venous insufficiency. This prospective interventional study aims to evaluate the safety and clinical effectiveness of endovascular embolization in relieving symptoms and improving quality of life in women diagnosed with PCS

Eligibility criteria

Qualifiers

Female patients aged 18 years or older.

Chronic pelvic pain for more than 6 months.

Clinical suspicion of pelvic congestion syndrome.

Imaging findings consistent with pelvic congestion syndrome on Doppler ultrasound, CT venography, MR venography, or catheter venography.

Disqualifiers

Pregnancy.

Active pelvic inflammatory disease.

Known pelvic malignancy.

Chronic pelvic pain due to other identifiable causes (e.g., endometriosis, large uterine fibroids).

Trial design

Treatments tested in this trial

  • Endovascular embolization

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators